Thr161

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Thr161 - CDK20 (human)

Site Information
PDGSRLYtHQVATRW SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 10154706

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Disease tissue studied:	breast cancer ( 1 ) , breast cancer, surrounding tissue ( 1 )
Relevant cell line - cell type - tissue:	breast ( 1 )

References
1	Rikova K (2008) CST Curation Set: 4106; Year: 2008; Biosample/Treatment: tissue, breast/untreated; Disease: breast cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: (F/Y)p[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho(Ser/Thr) Phe Antibody Cat#: 9631 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.